Please enable JavaScript to continue using this application.

Compare $PBLS vs $RCUS | Chartloom

Compare

$PBLS vs $RCUS

Parabilis Medicines Inc · Arcus Biosciences Inc

PBLS

Parabilis Medicines Inc

RCUS

Arcus Biosciences Inc

Compare $PBLS vs $RCUS

Comparing Parabilis Medicines Inc and Arcus Biosciences Inc

PBLSParabilis Medicines Inc

RCUSArcus Biosciences Inc

PBLSParabilis Medicines Inc

Market cap

$3.20B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

581.53x

Rev growth (TTM)

—

YTD performance

-13.0%

52W performance

-13.0%

FCF yield

-1.7%

RCUSArcus Biosciences Inc

Market cap

$3.07B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

84.08x

Rev growth (TTM)

-55.3%

YTD performance

4.8%

52W performance

62.2%

FCF yield

-15.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PBLS

RCUS

Detailed metrics comparison

PBLS

Parabilis Medicines Inc

RCUS

Arcus Biosciences Inc

Market Cap

PBLS$3.20B

RCUS$3.07B

Enterprise Value

PBLS$2.12B

RCUS$3.02B

Price

PBLS$27.48

RCUS$24.41

P/E Ratio

PBLSN/A

RCUSN/A

P/S Ratio

PBLS21,642.36x

RCUS26.24x

EV/Sales

PBLS14,348.08x

RCUS25.82x

EV/EBITDA

PBLS0.00x

RCUS37.63x

P/B Ratio

PBLS3.57x

RCUS6.71x

P/FCF Ratio

PBLSN/A

RCUSN/A

EV/FCF

PBLS-39.47x

RCUS-6.36x

PEG Ratio

PBLSN/A

RCUSN/A

Forward P/E (NTM)

PBLSN/A

RCUSN/A

Forward P/S (NTM)

PBLS581.53x

RCUS84.08x

Revenue (TTM)

PBLS$148K

RCUS$117M

Revenue Growth (YoY)

PBLSN/A

RCUS-55.3%

Forward Rev Growth

PBLS212.5%

RCUS-34.4%

Gross Margin (TTM)

PBLS0.0%

RCUS0.0%

Operating Margin (TTM)

PBLS0.0%

RCUS0.0%

EBITDA Margin (TTM)

PBLS-65635.1%

RCUS-406.8%

Net Margin (TTM)

PBLS-93131.8%

RCUS-393.2%

FCF Margin (TTM)

PBLS-36356.1%

RCUS-406.0%

Net Income (TTM)

PBLS$-138M

RCUS$-460M

FCF (TTM)

PBLS$-54M

RCUS$-475M

EPS (TTM)

PBLS-$1.12

RCUS-$3.65

ROE (TTM)

PBLS0.0%

RCUS-8954.0%

ROA (TTM)

PBLS0.0%

RCUS-4561.0%

ROIC (TTM)

PBLS0.0%

RCUS-7501.0%

Cash

PBLS$1.09B

RCUS$150M

Debt

PBLS$8M

RCUS$101M

Net Cash/Debt

PBLS$1.08B

RCUS$49M

Current Ratio (TTM)

PBLS17.91x

RCUS3.82x

Quick Ratio (TTM)

PBLS17.83x

RCUS3.75x

Debt/Equity (TTM)

PBLS0.01x

RCUS0.22x

Debt/Assets (TTM)

PBLS0.0%

RCUS0.0%

Interest Coverage (TTM)

PBLSN/A

RCUSN/A

Net Debt/EBITDA (TTM)

PBLS0.00x

RCUS0.00x

Beta

PBLS-1.08

RCUS1.05

52W Performance

PBLS-13.0%

RCUS62.2%

YTD Performance

PBLS-13.0%

RCUS4.8%

% from 52W High

PBLS-35.3%

RCUS-23.1%

% from 52W Low

PBLS12.1%

RCUS71.2%

Asset Turnover (TTM)

PBLS0.00x

RCUS0.12x

FCF Yield (TTM)

PBLS-1.7%

RCUS-15.5%

Earnings Yield (TTM)

PBLS-4.3%

RCUS-15.0%

Dividend Yield (TTM)

PBLSN/A

RCUSN/A

Rule of 40

PBLS-36,356.1

RCUS-461.3

EV/GP/RG

PBLSN/A

RCUSN/A

Ticker research

View PBLS research View RCUS research

Metric	PBLS Parabilis Medicines Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.20B	$3.07B
Enterprise Value	$2.12B	$3.02B
Price	$27.48	$24.41
P/E Ratio	N/A	N/A
P/S Ratio	21,642.36x	26.24x
EV/Sales	14,348.08x	25.82x
EV/EBITDA	0.00x	37.63x
P/B Ratio	3.57x	6.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-39.47x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	581.53x	84.08x
Revenue & Growth
Revenue (TTM)	$148K	$117M
Revenue Growth (YoY)	N/A	-55.3%
Forward Rev Growth	212.5%	-34.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-65635.1%	-406.8%
Net Margin (TTM)	-93131.8%	-393.2%
FCF Margin (TTM)	-36356.1%	-406.0%
Net Income (TTM)	$-138M	$-460M
FCF (TTM)	$-54M	$-475M
EPS (TTM)	-$1.12	-$3.65
ROE (TTM)	0.0%	-8954.0%
ROA (TTM)	0.0%	-4561.0%
ROIC (TTM)	0.0%	-7501.0%
Financial Health
Cash	$1.09B	$150M
Debt	$8M	$101M
Net Cash/Debt	$1.08B	$49M
Current Ratio (TTM)	17.91x	3.82x
Quick Ratio (TTM)	17.83x	3.75x
Debt/Equity (TTM)	0.01x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.08	1.05
52W Performance	-13.0%	62.2%
YTD Performance	-13.0%	4.8%
% from 52W High	-35.3%	-23.1%
% from 52W Low	12.1%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-1.7%	-15.5%
Earnings Yield (TTM)	-4.3%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36,356.1	-461.3
EV/GP/RG	N/A	N/A
Ticker research	View PBLS research	View RCUS research

Valuation

P/S Ratio

RCUS

26.24x

PBLS

21,642.36x

EV/FCF

PBLS

-39.47x

RCUS

-6.36x

Growth & revenue

Revenue Growth TTM

RCUS

-55.3%

Forward Revenue Growth

PBLS

212.5%

RCUS

-34.4%

Profitability & performance

Gross Margin

PBLS

0.0%

RCUS

0.0%

ROE

PBLS

0.0%

RCUS

-8954.0%

FCF Yield %

PBLS

-1.7%

RCUS

-15.5%

52-Week Performance

RCUS

62.2%

PBLS

-13.0%

Detailed metrics comparison

PBLS

Parabilis Medicines Inc

RCUS

Arcus Biosciences Inc

Market Cap

PBLS$3.20B

RCUS$3.07B

Enterprise Value

PBLS$2.12B

RCUS$3.02B

Price

PBLS$27.48

RCUS$24.41

P/E Ratio

PBLSN/A

RCUSN/A

P/S Ratio

PBLS21,642.36x

RCUS26.24x

EV/Sales

PBLS14,348.08x

RCUS25.82x

EV/EBITDA

PBLS0.00x

RCUS37.63x

P/B Ratio

PBLS3.57x

RCUS6.71x

P/FCF Ratio

PBLSN/A

RCUSN/A

EV/FCF

PBLS-39.47x

RCUS-6.36x

PEG Ratio

PBLSN/A

RCUSN/A

Forward P/E (NTM)

PBLSN/A

RCUSN/A

Forward P/S (NTM)

PBLS581.53x

RCUS84.08x

Revenue (TTM)

PBLS$148K

RCUS$117M

Revenue Growth (YoY)

PBLSN/A

RCUS-55.3%

Forward Rev Growth

PBLS212.5%

RCUS-34.4%

Gross Margin (TTM)

PBLS0.0%

RCUS0.0%

Operating Margin (TTM)

PBLS0.0%

RCUS0.0%

EBITDA Margin (TTM)

PBLS-65635.1%

RCUS-406.8%

Net Margin (TTM)

PBLS-93131.8%

RCUS-393.2%

FCF Margin (TTM)

PBLS-36356.1%

RCUS-406.0%

Net Income (TTM)

PBLS$-138M

RCUS$-460M

FCF (TTM)

PBLS$-54M

RCUS$-475M

EPS (TTM)

PBLS-$1.12

RCUS-$3.65

ROE (TTM)

PBLS0.0%

RCUS-8954.0%

ROA (TTM)

PBLS0.0%

RCUS-4561.0%

ROIC (TTM)

PBLS0.0%

RCUS-7501.0%

Cash

PBLS$1.09B

RCUS$150M

Debt

PBLS$8M

RCUS$101M

Net Cash/Debt

PBLS$1.08B

RCUS$49M

Current Ratio (TTM)

PBLS17.91x

RCUS3.82x

Quick Ratio (TTM)

PBLS17.83x

RCUS3.75x

Debt/Equity (TTM)

PBLS0.01x

RCUS0.22x

Debt/Assets (TTM)

PBLS0.0%

RCUS0.0%

Interest Coverage (TTM)

PBLSN/A

RCUSN/A

Net Debt/EBITDA (TTM)

PBLS0.00x

RCUS0.00x

Beta

PBLS-1.08

RCUS1.05

52W Performance

PBLS-13.0%

RCUS62.2%

YTD Performance

PBLS-13.0%

RCUS4.8%

% from 52W High

PBLS-35.3%

RCUS-23.1%

% from 52W Low

PBLS12.1%

RCUS71.2%

Asset Turnover (TTM)

PBLS0.00x

RCUS0.12x

FCF Yield (TTM)

PBLS-1.7%

RCUS-15.5%

Earnings Yield (TTM)

PBLS-4.3%

RCUS-15.0%

Dividend Yield (TTM)

PBLSN/A

RCUSN/A

Rule of 40

PBLS-36,356.1

RCUS-461.3

EV/GP/RG

PBLSN/A

RCUSN/A

Ticker research

View PBLS research View RCUS research

Metric	PBLS Parabilis Medicines Inc	RCUS Arcus Biosciences Inc
Market & Valuation
Market Cap	$3.20B	$3.07B
Enterprise Value	$2.12B	$3.02B
Price	$27.48	$24.41
P/E Ratio	N/A	N/A
P/S Ratio	21,642.36x	26.24x
EV/Sales	14,348.08x	25.82x
EV/EBITDA	0.00x	37.63x
P/B Ratio	3.57x	6.71x
P/FCF Ratio	N/A	N/A
EV/FCF	-39.47x	-6.36x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	581.53x	84.08x
Revenue & Growth
Revenue (TTM)	$148K	$117M
Revenue Growth (YoY)	N/A	-55.3%
Forward Rev Growth	212.5%	-34.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-65635.1%	-406.8%
Net Margin (TTM)	-93131.8%	-393.2%
FCF Margin (TTM)	-36356.1%	-406.0%
Net Income (TTM)	$-138M	$-460M
FCF (TTM)	$-54M	$-475M
EPS (TTM)	-$1.12	-$3.65
ROE (TTM)	0.0%	-8954.0%
ROA (TTM)	0.0%	-4561.0%
ROIC (TTM)	0.0%	-7501.0%
Financial Health
Cash	$1.09B	$150M
Debt	$8M	$101M
Net Cash/Debt	$1.08B	$49M
Current Ratio (TTM)	17.91x	3.82x
Quick Ratio (TTM)	17.83x	3.75x
Debt/Equity (TTM)	0.01x	0.22x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.08	1.05
52W Performance	-13.0%	62.2%
YTD Performance	-13.0%	4.8%
% from 52W High	-35.3%	-23.1%
% from 52W Low	12.1%	71.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.12x
FCF Yield (TTM)	-1.7%	-15.5%
Earnings Yield (TTM)	-4.3%	-15.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-36,356.1	-461.3
EV/GP/RG	N/A	N/A
Ticker research	View PBLS research	View RCUS research